AT366683B - Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triazolen und deren salzen - Google Patents
Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triazolen und deren salzenInfo
- Publication number
- AT366683B AT366683B AT0063678A AT63678A AT366683B AT 366683 B AT366683 B AT 366683B AT 0063678 A AT0063678 A AT 0063678A AT 63678 A AT63678 A AT 63678A AT 366683 B AT366683 B AT 366683B
- Authority
- AT
- Austria
- Prior art keywords
- 3dioxolan
- triazoles
- imidazoles
- ylmethyl
- salts
- Prior art date
Links
- -1 1,3DIOXOLAN-2-YLMETHYL Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76426377A | 1977-01-31 | 1977-01-31 | |
US05/853,728 US4144346A (en) | 1977-01-31 | 1977-11-21 | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US06/001,612 US4223036A (en) | 1977-01-31 | 1979-01-08 | 1-(1,3-Dioxolan-2-ylmethyl)-1H-1,2,4-triazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA63678A ATA63678A (de) | 1981-09-15 |
AT366683B true AT366683B (de) | 1982-04-26 |
Family
ID=27117424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0063678A AT366683B (de) | 1977-01-31 | 1978-01-30 | Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triazolen und deren salzen |
Country Status (36)
Country | Link |
---|---|
US (4) | US4144346A (de) |
JP (1) | JPS5395973A (de) |
KR (1) | KR810000675B1 (de) |
AT (1) | AT366683B (de) |
AU (1) | AU521329B2 (de) |
BE (1) | BE863382A (de) |
CA (1) | CA1094559A (de) |
CH (1) | CH644118A5 (de) |
CS (1) | CS194833B2 (de) |
CY (1) | CY1192A (de) |
DE (1) | DE2804096A1 (de) |
DK (1) | DK158042C (de) |
ES (1) | ES465981A1 (de) |
FI (1) | FI63398C (de) |
FR (1) | FR2378778A1 (de) |
GB (1) | GB1594859A (de) |
GR (1) | GR62553B (de) |
HK (1) | HK9182A (de) |
HU (2) | HU184842B (de) |
IE (1) | IE46035B1 (de) |
IL (1) | IL53923A (de) |
IT (1) | IT1155800B (de) |
KE (1) | KE3270A (de) |
LU (1) | LU78960A1 (de) |
LV (1) | LV5015A3 (de) |
MY (1) | MY8400209A (de) |
NL (1) | NL188578C (de) |
NO (1) | NO148643C (de) |
NZ (1) | NZ186275A (de) |
PH (1) | PH14635A (de) |
PL (1) | PL113973B1 (de) |
PT (1) | PT67600B (de) |
SE (1) | SE439773B (de) |
SU (1) | SU786899A3 (de) |
YU (1) | YU40319B (de) |
ZA (1) | ZA78548B (de) |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4232034A (en) * | 1977-01-31 | 1980-11-04 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4244964A (en) * | 1977-01-31 | 1981-01-13 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazoles |
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4229460A (en) * | 1977-01-31 | 1980-10-21 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazoles having antifungal and antibacterial properties |
US4368200A (en) * | 1978-06-23 | 1983-01-11 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of (4-phenyl-piperazine-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
EP0006722B1 (de) * | 1978-07-03 | 1984-09-05 | Janssen Pharmaceutica N.V. | (4-(Piperazin-1-yl-phenyloxymethyl)-1.3-dioxolan-2-ylmethyl)-1H-imidazol- und -1H-1.2.4-triazol-Derivate, ihre Herstellung und ihre Verwendung als Fungizide und Bacterizide |
US4287195A (en) * | 1978-07-14 | 1981-09-01 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles |
US4338327A (en) * | 1978-10-06 | 1982-07-06 | Janssen Pharmaceutica, N.V. | Substituted 1-(2-aryl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazoles |
US4503055A (en) * | 1979-03-26 | 1985-03-05 | Janssen Pharmaceutica, N.V. | Derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles |
DE3039087A1 (de) * | 1980-10-16 | 1982-05-19 | Hoechst Ag, 6000 Frankfurt | 1-(1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung |
US4490530A (en) * | 1981-01-14 | 1984-12-25 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles |
DE3104311A1 (de) * | 1981-02-07 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | 2-azolylmethyl-1,3-dioxolan- und -dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
US4490540A (en) * | 1981-09-14 | 1984-12-25 | Janssen Pharmaceutica N.V. | (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives |
US4375474A (en) * | 1982-02-11 | 1983-03-01 | Syntex (U.S.A.) Inc. | Dioxalane containing imidazole compounds, compositions and use |
US4491588A (en) * | 1982-03-31 | 1985-01-01 | University Of Tennessee Research Corporation | Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics |
US4942162A (en) * | 1982-03-31 | 1990-07-17 | University Of Tennessee Research Corporation | Topical treatment of seborrheic dermatitis with ketoconazole |
EP0094052A3 (de) * | 1982-05-12 | 1984-07-18 | Hoechst Aktiengesellschaft | 1-(1,3-Dioxolan-2-yl-methyl)-1H-imidazole und -1H-1,2,4-triazole und deren Salze, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung |
JPS59139380A (ja) * | 1983-01-28 | 1984-08-10 | Yoshiki Hamada | 1,3―ジオキソランアシラート誘導体及びその製造法 |
US4735942A (en) * | 1984-01-09 | 1988-04-05 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]-methyl]-1H-imidazoles and 1H-1,2,4-triazoles having antimicrobial properties |
US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
DE3484023D1 (de) * | 1983-03-03 | 1991-03-07 | Basf Ag | Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
DE3308554A1 (de) * | 1983-03-10 | 1984-09-13 | Hoechst Ag, 6230 Frankfurt | 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung |
US4569935A (en) * | 1983-03-17 | 1986-02-11 | University Of Tennessee Research Corp. | Topical treatment of psoriasis with imidazole antibiotics |
DE3401694A1 (de) * | 1984-01-19 | 1985-07-25 | Basf Ag, 6700 Ludwigshafen | Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3404819A1 (de) * | 1984-02-10 | 1985-08-14 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Neue 1,3-dioxolanylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltendes arzneimittel |
EP0165781A1 (de) * | 1984-06-18 | 1985-12-27 | Eli Lilly And Company | Aromatase inhibierende N-substituierte Imidazolderivate |
DK354185A (da) * | 1984-08-31 | 1986-03-01 | Hoffmann La Roche | 1,3-dioxolanderivater |
US4661602A (en) * | 1985-03-29 | 1987-04-28 | G. D. Searle & Co. | Substituted alkyl imidazole derivatives |
US4628104A (en) * | 1985-04-08 | 1986-12-09 | G. D. Searle & Co. | Imidazole ketone derivatives |
US4761483A (en) * | 1985-06-26 | 1988-08-02 | G. D. Searle & Co. | Chloro-substituted ketone imidazole derivatives |
CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
FR2593816B1 (fr) * | 1986-02-04 | 1989-02-10 | Ire Celltarg Sa | Derives d'imidazoles, procede de preparation et compositions fongicides les contenant |
DE3609596A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
DE3609597A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
DE3609598A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
DE3622791A1 (de) * | 1986-07-07 | 1988-01-21 | Heumann Pharma Gmbh & Co | Neue 1,4-piperazinderivate, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltendes arzneimittel |
US4788190A (en) * | 1986-12-24 | 1988-11-29 | Schering Corporation | 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds |
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
AU614818B2 (en) * | 1988-03-28 | 1991-09-12 | Janssen Pharmaceutica N.V. | 2-imidazolylmethyl-1,3-dioxolanyl methylthiophenyl carbamate derivatives and their use as antineoplastic agents |
US4992421A (en) * | 1988-04-19 | 1991-02-12 | Abbott Laboratories | Luteinizing hormone releasing hormone antagonist |
GB8910069D0 (en) * | 1989-05-03 | 1989-06-21 | Janssen Pharmaceutica Nv | Method of topically treating acne vulgaris |
GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
US5158949A (en) * | 1990-12-20 | 1992-10-27 | Syntex (U.S.A.) Inc. | 1,3-dioxolane derivatives as cholesterol-lowering agents |
JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
US5641494A (en) * | 1992-03-20 | 1997-06-24 | Janssen Pharmaceutica N.V. | Agent for regulating the greasiness of the skin |
AU666535B2 (en) * | 1992-03-20 | 1996-02-15 | Janssen Pharmaceutica N.V. | Agent for regulating the greasiness of the skin |
US5274108A (en) * | 1992-06-18 | 1993-12-28 | Syntex (U.S.A.) Inc. | Process for preparing 1,3-dioxolane derivatives |
WO1994014447A1 (en) * | 1992-12-22 | 1994-07-07 | Sepracor, Inc. | Methods and compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections |
AU5851594A (en) * | 1992-12-22 | 1994-07-19 | Georgetown University | Methods and compositions of (+) ketoconazole for treating fungal, yeast and dermatophyte infections |
US6022532A (en) * | 1993-03-12 | 2000-02-08 | Janssen Pharmaceutica, N.V. | Agent for regulating the greasiness of the skin |
IL111584A0 (en) * | 1993-11-18 | 1995-01-24 | Merck & Co Inc | Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them |
JPH09510185A (ja) * | 1993-12-23 | 1997-10-14 | ザ、プロクター、エンド、ギャンブル、カンパニー | 組織モイスチャライジング及び抗菌組成物 |
DE69426727D1 (de) * | 1993-12-23 | 2001-03-29 | Procter & Gamble | Antimikrobielle zusammensetzungen für abwischtücher |
US5565478A (en) * | 1994-03-14 | 1996-10-15 | The United States Of America As Represented By The Department Of Health & Human Services | Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs |
TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
GB9509631D0 (en) * | 1995-05-12 | 1995-07-05 | Sandoz Ltd | Antifungal combination |
US5728834A (en) * | 1996-11-14 | 1998-03-17 | Wyckoff Chemical Company, Inc. | Process for preparation of 4-aryl-1,2,4-triazol-3-ones |
JP2002510292A (ja) * | 1997-07-02 | 2002-04-02 | ニュートロジーナ・コーポレイション | 脂漏性皮膚炎、フケ、乾癬及びニキビを治療するジクロロフェニルイミダゾールジオキソランを含有する組成物の使用方法及び該組成物 |
AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
ES2141667B1 (es) * | 1997-11-04 | 2000-11-16 | Sint Quimica Sa | Procedimiento de preparacion del cis (+ -)-1-(4-(2-(2,4-diclorofenil)-2-(1h, 1,2,4-triazol-1-ilmetil)-1,3-dioxolan-4-il) metoxi) fenil)-4-(1-metiletil) piperazina. |
US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
KR20000051143A (ko) * | 1999-01-19 | 2000-08-16 | 김충섭 | 불소화 비닐기가 치환된 신규의 아졸계 유도체 및 그의 제조방법 |
US6080744A (en) * | 1999-02-10 | 2000-06-27 | Ayon-Covarrubias; Blas | Topical antifungal treatment |
US6812238B1 (en) * | 1999-11-02 | 2004-11-02 | Basilea Pharmaceutica Ag | N-substituted carbamoyloxyalkyl-azolium derivatives |
US6673373B2 (en) | 2001-02-01 | 2004-01-06 | Carlsbad Technology Inc. | Antifungal formulation and the methods for manufacturing and using the same |
CN1536986B (zh) * | 2001-03-27 | 2012-07-04 | 沃纳奇尔科特(爱尔兰)有限公司 | 用于抗微生物剂给药的阴道内药物递送装置 |
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
CN1628109A (zh) * | 2002-02-05 | 2005-06-15 | 诺沃挪第克公司 | 新颖的芳基-与杂芳基-哌嗪 |
US8404751B2 (en) * | 2002-09-27 | 2013-03-26 | Hallux, Inc. | Subunguicide, and method for treating onychomycosis |
AU2004259263B2 (en) | 2003-07-29 | 2010-12-16 | High Point Pharmaceuticals, Llc | Pyridazinyl- piperazines and their use as histamine H3 receptor ligands |
US20050074494A1 (en) * | 2003-10-06 | 2005-04-07 | Xiu-Xiu Cheng | Itraconazole immediate release formulation |
KR100517726B1 (ko) * | 2003-10-30 | 2005-09-27 | 동부정밀화학 주식회사 | 3-클로로-4-[4-메틸-2-(1h-1,2,4-트리아졸-1-일메틸)-1,3디옥솔란-2일]페닐4-클로로페닐에테르 화합물의 제조방법 |
CA2614116A1 (en) | 2005-07-04 | 2007-01-11 | Novo Nordisk A/S | Novel medicaments |
US8318927B2 (en) | 2006-05-23 | 2012-11-27 | High Point Pharmaceuticals, Llc | 6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament |
CN102295606A (zh) | 2006-05-29 | 2011-12-28 | 高点制药有限责任公司 | 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体 |
WO2008033466A2 (en) * | 2006-09-14 | 2008-03-20 | Combinatorx (Singapore) Pre. Ltd. | Compositions and methods for treatment of viral diseases |
CA2664800A1 (en) | 2006-10-02 | 2008-04-10 | Timothy Andrew Stewart | Ketoconazole enantiomer in humans |
TWI426918B (zh) * | 2007-02-12 | 2014-02-21 | Merck Sharp & Dohme | Il-23拮抗劑於治療感染之用途 |
EP2014656A3 (de) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Neue heterocyclische H3-Antagonisten |
PT2211626T (pt) | 2007-08-29 | 2019-10-01 | Ganeden Biotech Inc | Produtos cozinhados em forno |
JP2011500055A (ja) * | 2007-10-16 | 2011-01-06 | ガネーデン バイオテック インコーポレイテッド | 飲料組成物 |
CL2009000902A1 (es) * | 2008-04-15 | 2010-07-23 | Merck Sharp & Dohme | Composicion que comprende posaconazol disuelto o disperso molecularmente en un polimero derivado de hidroxipropilcelulosa; formulacion farmaceutica que comprende a la composion; un proceso para preparar a la composicion mediante fusioextrusion; y su uso para tratar una infeccion micotica. |
JP2011516613A (ja) * | 2008-04-15 | 2011-05-26 | シェーリング コーポレイション | 好ましくはポサコナゾールおよびhpmcasを含む固体分散物中の経口用薬学的組成物 |
US7788209B2 (en) * | 2008-05-05 | 2010-08-31 | United Technologies Corporation | Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning |
JP2009286756A (ja) | 2008-05-30 | 2009-12-10 | Fujifilm Finechemicals Co Ltd | トリアゾール誘導体またはその塩 |
CN101302213B (zh) * | 2008-06-30 | 2012-07-25 | 寿光富康制药有限公司 | 顺式-2-(2,4-二氯苯基)-2-([1,2,4]-三唑-1-甲基)-[1,3]二氧戊环-4-甲基甲磺酸酯的制备方法 |
CN101665490B (zh) * | 2008-09-01 | 2012-01-04 | 浙江东亚药业有限公司 | 酮康唑衍生物的制备方法 |
ES2595733T3 (es) | 2008-10-16 | 2017-01-03 | Ganeden Biotech, Inc. | Composiciones probióticas a base de cereales |
ES2639364T3 (es) | 2009-04-29 | 2017-10-26 | Ganeden Biotech, Inc. | Formulación de membrana celular bacteriana |
BRPI0904249B1 (pt) | 2009-08-28 | 2018-03-06 | Biolab Sanus Farmacêutica Ltda. | Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica |
CN101993436B (zh) * | 2010-10-29 | 2012-06-27 | 杭州欧拓普生物技术有限公司 | 一种咪唑类抗真菌药物衍生物的制备方法 |
CN102070620B (zh) * | 2011-01-25 | 2012-12-12 | 南京白敬宇制药有限责任公司 | 一种抑菌酯的制备方法 |
WO2012135499A1 (en) | 2011-03-31 | 2012-10-04 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
CN102627633A (zh) * | 2012-03-21 | 2012-08-08 | 浙江丽晶化学有限公司 | 新康唑提纯新方法 |
US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
WO2014122530A1 (en) * | 2013-02-06 | 2014-08-14 | Cortendo Ab (Publ) | Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of use |
US9498612B2 (en) | 2013-03-14 | 2016-11-22 | Hallux, Inc. | Method of treating infections, diseases or disorders of nail unit |
CN104447711A (zh) * | 2013-09-23 | 2015-03-25 | 南京白敬宇制药有限责任公司 | 合成酮康唑的方法 |
CA2925294A1 (en) * | 2013-09-25 | 2015-04-02 | Cortendo Ab (Publ) | Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibitng cytochrome p450 inhibition |
US10149848B2 (en) | 2015-12-09 | 2018-12-11 | Cipla Limited | Method for the treatment of bladder cancer |
US11185548B2 (en) | 2016-12-23 | 2021-11-30 | Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases |
ES2962526T3 (es) | 2017-06-22 | 2024-03-19 | Cipla Ltd | Secretagogos PAR-4 para el tratamiento del cáncer |
MX2020014203A (es) | 2018-06-21 | 2021-05-27 | Yumanity Therapeutics Inc | Composiciones y métodos para el tratamiento y la prevención de trastornos neurológicos. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3658797A (en) * | 1968-08-06 | 1972-04-25 | Lilly Co Eli | Novel 5-nitroimidazole antiparasitic agents |
US3575999A (en) * | 1968-08-19 | 1971-04-20 | Janssen Pharmaceutica Nv | Ketal derivatives of imidazole |
US4079062A (en) * | 1974-11-18 | 1978-03-14 | Janssen Pharmaceutica N.V. | Triazole derivatives |
US3936470A (en) * | 1975-01-27 | 1976-02-03 | Janssen Pharmaceutica N.V. | 1,3-Dioxolan-2-ylmethylimidazoles |
CA1065873A (en) * | 1975-01-27 | 1979-11-06 | Janssen Pharmaceutica Naamloze Vennootschap | Imidazole derivatives |
US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4160838A (en) * | 1977-06-02 | 1979-07-10 | Janssen Pharmaceutica N.V. | Antimicrobial and plant-growth-regulating triazole derivatives |
-
1977
- 1977-11-21 US US05/853,728 patent/US4144346A/en not_active Expired - Lifetime
- 1977-12-23 CY CY1192A patent/CY1192A/xx unknown
- 1977-12-23 GB GB53851/77A patent/GB1594859A/en not_active Expired
-
1978
- 1978-01-13 ES ES465981A patent/ES465981A1/es not_active Expired
- 1978-01-19 NZ NZ186275A patent/NZ186275A/en unknown
- 1978-01-25 GR GR55267A patent/GR62553B/el unknown
- 1978-01-25 KR KR7800187A patent/KR810000675B1/ko active
- 1978-01-26 CA CA295,761A patent/CA1094559A/en not_active Expired
- 1978-01-27 BE BE184676A patent/BE863382A/xx not_active IP Right Cessation
- 1978-01-30 FI FI780294A patent/FI63398C/fi not_active IP Right Cessation
- 1978-01-30 DK DK042678A patent/DK158042C/da not_active IP Right Cessation
- 1978-01-30 HU HU81149A patent/HU184842B/hu unknown
- 1978-01-30 LU LU78960A patent/LU78960A1/xx unknown
- 1978-01-30 PL PL1978204348A patent/PL113973B1/pl unknown
- 1978-01-30 HU HU78JA808A patent/HU177646B/hu unknown
- 1978-01-30 IL IL53923A patent/IL53923A/xx unknown
- 1978-01-30 PT PT67600A patent/PT67600B/pt unknown
- 1978-01-30 SE SE7801088A patent/SE439773B/sv not_active IP Right Cessation
- 1978-01-30 NO NO780335A patent/NO148643C/no unknown
- 1978-01-30 IT IT47837/78A patent/IT1155800B/it active
- 1978-01-30 IE IE195/78A patent/IE46035B1/en not_active IP Right Cessation
- 1978-01-30 SU SU782570553A patent/SU786899A3/ru active
- 1978-01-30 NL NLAANVRAGE7801048,A patent/NL188578C/xx not_active IP Right Cessation
- 1978-01-30 AT AT0063678A patent/AT366683B/de active
- 1978-01-30 JP JP841778A patent/JPS5395973A/ja active Granted
- 1978-01-30 ZA ZA00780548A patent/ZA78548B/xx unknown
- 1978-01-30 FR FR7802564A patent/FR2378778A1/fr active Granted
- 1978-01-31 YU YU221/78A patent/YU40319B/xx unknown
- 1978-01-31 DE DE19782804096 patent/DE2804096A1/de active Granted
- 1978-01-31 CS CS78651A patent/CS194833B2/cs unknown
- 1978-01-31 AU AU32850/78A patent/AU521329B2/en not_active Expired
- 1978-01-31 PH PH20735A patent/PH14635A/en unknown
- 1978-01-31 CH CH105878A patent/CH644118A5/de not_active IP Right Cessation
-
1979
- 1979-01-08 US US06/001,612 patent/US4223036A/en not_active Expired - Lifetime
- 1979-01-08 US US06/001,613 patent/US4335125A/en not_active Expired - Lifetime
-
1980
- 1980-02-15 US US06/351,671 patent/US4358449A/en not_active Expired - Lifetime
-
1982
- 1982-02-25 HK HK91/82A patent/HK9182A/xx not_active IP Right Cessation
-
1983
- 1983-04-02 KE KE3270A patent/KE3270A/xx unknown
-
1984
- 1984-12-30 MY MY209/84A patent/MY8400209A/xx unknown
-
1992
- 1992-11-09 LV LV920186A patent/LV5015A3/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT366683B (de) | Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triazolen und deren salzen | |
AT363479B (de) | Verfahren zur herstellung von neuen imidazo-chinazolinen, deren tautomeren und salzen | |
AT368152B (de) | Verfahren zur herstellung von neuen imidazolderivaten, deren stereoisomeren und salzen | |
AT363457B (de) | Verfahren zur herstellung von neuen substituierten 1-(3-aminosulfonylphenyl)-2-alkylaminoaethanolen und deren saeureadditionssalzen | |
AT364829B (de) | Verfahren zur herstellung von neuen nitroimidazolen und von deren salzen | |
AT373880B (de) | Verfahren zur herstellung von neuen imidazolderivaten und von deren salzen | |
AT363952B (de) | Verfahren zur herstellung von neuen triazinverbindungen und deren salzen | |
AT363491B (de) | Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen | |
AT367419B (de) | Verfahren zur herstellung von neuen heterocyclischen derivaten von 1-(1,3-dioxolan-2ylmethyl)-1h-imidazolen und -1h-1,2,4-triazolen, deren salzen und isomeren | |
AT357553B (de) | Verfahren zur herstellung von neuen 2-(2,2- diarylalkyl)-1-azabicyclo(2.2.2)octanen und von deren salzen | |
AT355018B (de) | Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen | |
AT373881B (de) | Verfahren zur herstellung von neuen imidazolderivaten, deren salzen, stereoisomeren und racematen | |
AT365188B (de) | Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen | |
AT357144B (de) | Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen | |
AT359474B (de) | Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen | |
AT359070B (de) | Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen | |
AT360997B (de) | Verfahren zur herstellung von neuen 1-(3-(3,4,5 -trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl- piperazin-derivaten und deren salzen | |
AT352139B (de) | Verfahren zur herstellung von neuen 2,9- dioxatricyclo-(4,3,1,03,7)decanen und deren salzen | |
AT360999B (de) | Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen | |
AT358050B (de) | Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen | |
ATA320578A (de) | Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen | |
AT366665B (de) | Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen | |
ATA678478A (de) | Verfahren zur herstellung von neuen 4-alkyl-3,5-dioxo-pyrazolidinylderivaten und von deren salzen | |
ATA42180A (de) | Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen | |
ATA42280A (de) | Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |